Srini Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DEXTROMETHORPHAN HYDROBROMIDE USP, with a corresponding US DMF Number 32848.
Remarkably, this DMF maintains an Active status since its submission on June 04, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2021, and payment made on July 29, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II